Caption Management’s Cidara Therapeutics CDTX Stock Holding History

Caption Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-44,100	Closed	-$9.74M	–	1609
2025 Q4	$9.74M	Buy	44,100 +100	+0.2%	+$16.2K	0.07%	341
2025 Q3	$4.21M	Sell	44,000 -254,000	-85%	-$16.2M	0.03%	559
2025 Q2	$14.5M	Buy	+298,000	New	+$7.16M	0.16%	130

Caption Management's CDTX Position: Q4 2025 in Review

Caption Management sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 29,806 shares — an estimated $4.82M sold.

Caption Management first reported a position in CDTX in Q2 2025 and held it in 2 quarters. The position peaked at $13.1M in Q2 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

Caption Management reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
Caption Management sold 29,806 Cidara Therapeutics shares in Q4 2025, an estimated $4.82M.
Caption Management first reported a position in Cidara Therapeutics in Q2 2025 and held it in 2 quarters.
Caption Management's Cidara Therapeutics position peaked at $13.1M in Q2 2025.
255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.